From: Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
Mice
MIN-O size at 5 weeks after transplantation
Tumor latency
%FPF (no.)
Relative to control
P
TE50 (weeks)
Control
67.50 ± 12.58 (4)
1
0.0001
6.60
Ovariectomized
22.86 ± 7.56 (7)
0.34
10.10